Mode
Text Size
Log in / Sign up
N/A N=277 Randomized Treatment

Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin

Community-acquired Pneumonia

Enrolled (actual)
277
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcome: Primary: Vancomycin-free Hours Alive — 105.7; 109.7 Hours

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
MRSA Nasal Swab PCR (Diagnostic_test)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Vanderbilt University Medical Center
Primary completion
Feb 2025

Outcome Measures

OutcomeResultp-value
PRIMARY
Vancomycin-free Hours Alive
105.7; 109.7
SECONDARY
Time Alive Off Vancomycin
128; 138
SECONDARY
30-day All-cause Mortality
56; 31

Summary

This is a single center, pragmatic, randomized clinical trial (pRCT) examining whether reporting the results of a negative rapid PCR back to the provider via a pager alert results in decreased vancomycin utilization for critically ill adults with community-acquired pneumonia when compared with usual care.

Eligibility Criteria

Inclusion Criteria

  • Adult (age greater than or equal to 18) patients admitted/transferred to the Vanderbilt University Medical Center (VUMC) Medical Intensive Care Unit (MICU) from the VUMC Emergency Department or from a hospital floor within 48 hours of admission.
  • Suspicion for pneumonia on admission (defined as an indication for antibiotics of "respiratory infection" and/or an order for a respiratory culture i.e., sputum culture, tracheal aspirate culture, or bronchoalveolar lavage (BAL) culture).
  • No topical nasal decolonization during hospitalization prior to collection of MRSA nasal swab PCR.
  • Must match both of the following in either order:
  • The patient has been admitted to and physically located in the MICU.
  • The patient has received a continuing vancomycin order, or a pharmacokinetics consult for a continuing vancomycin order, no later than 24 hours following their physical admission to the MICU.

Exclusion Criteria

  • Hospital stay of longer than 48 hours prior to MICU admission.
  • Known to be a prisoner
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06272994). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search